Frank O'Donnell

Frank O'Donnell

Chief Executive Officer bei INHIBITOR THERAPEUTICS, INC.

Vermögen: 3 500 $ am 31.03.2024

74 Jahre
Health Technology
Consumer Services
Finance

Profil

Frank E.
O'Donnell
is the founder of BioDelivery Sciences International, Inc. (founded in 2000) and Hopkins Capital Group (founded in 1999).
He holds the title of Director at BioDelivery Sciences International, Inc. from 2018 to 2020 and was previously the Chief Executive Officer at Hopkins Capital Group.
Dr. O'Donnell was also the founder of Biotech Specialty Partners LLC, Repurposed Therapeutics, Inc., and RetinaPharma Technologies, Inc. Dr. O'Donnell's current job(s) included being the Executive Chairman & Chief Executive Officer at Inhibitor Therapeutics, Inc. since 2022, Chairman at PhotoVision Pharmaceuticals, Inc., Chairman at Defender Pharmaceuticals, Inc., Trustee at St. Louis University, and Trustee at Health Careers Foundation.
Dr. O'Donnell's former job(s) include being the Chairman & Chief Executive Officer at Accentia Biopharmaceuticals, Inc. from 2002 to 2012, Executive Chairman at BioVest International, Inc. from 2012 to 2013, Executive Chairman at Inhibitor Therapeutics, Inc. from 2013 to 2016, and Chairman-Ophthalmology Department at Saint Louis University School of Medicine.
Dr. O'Donnell's education history includes undergraduate studies at The Johns Hopkins University School of Medicine.
Dr. O'Donnell is also the founder of Biotech Specialty Partners LLC, Repurposed Therapeutics, Inc., RetinaPharma Technologies, Inc...

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
29.03.2024 50 000 ( 0,03% ) 3 500 $ 31.03.2024

Aktive Positionen von Frank O'Donnell

UnternehmenPositionBeginn
INHIBITOR THERAPEUTICS, INC. Chief Executive Officer 13.12.2022
Chief Executive Officer 01.01.1999
Health Careers Foundation Director/Board Member -
Chairman 08.06.2010
St. Louis University Director/Board Member 07.04.2011
Defender Pharmaceuticals, Inc. Chairman -
Alle aktiven Positionen von Frank O'Donnell

Ehemalige bekannte Positionen von Frank O'Donnell

UnternehmenPositionEnde
BIODELIVERY SCIENCES INTERNATIONAL, INC. Chief Executive Officer 22.08.2005
INHIBITOR THERAPEUTICS, INC. Chairman 22.11.2016
Chairman 01.03.2013
░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
Sehen Sie sich die Erfahrung von Frank O'Donnell im Detail an

Ausbildung von Frank O'Donnell

The Johns Hopkins University School of Medicine Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Frank O'Donnell im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
INHIBITOR THERAPEUTICS, INC.

Health Technology

Private Unternehmen11

Finance

Health Technology

Health Technology

Health Technology

Distribution Services

Health Careers Foundation

Health Technology

Commercial Services

Finance

Repurposed Therapeutics, Inc.

Defender Pharmaceuticals, Inc.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Frank O'Donnell